Global Legal Hackathon Toronto Node
6-8 March 2020
For registration and details please click here.
Picks of the week
Wuhan Institute of Virology of the China Academy of Sciences China said this week that they recently appplied for a new patent on an experimental Gilead Sciences Inc. drug, know as remdesivir, that might fight the coronavirus. According to the statement released on January 31, 2020 Gilead Sciences is working with health authorities in China to establish a randomized, controlled trial to determine whether remdesivir can safely and effectively be used to treat the novel coronavirus (2019-nCoV).
Last week the U.S. Patent and Trademark Office (USPTO) announced that David Gooder has been appointed as the new USPTO Commissioner for Trademarks, replacing Mary Boney Denison, who retired from the position in December 2019.